Zymergen Investor Alert: Class Action Lawsuit Filed | 2021-08-11 | Press Releases

Boston, Mass .– (Newsfile Corp. – Aug. 11, 2021) – Thornton law firm is alerting investors that a class action lawsuit has been filed on behalf of investors by Zymergen Inc. (NASDAQ: ZY). The case is currently at the main plaintiff stage. Investors who have acquired or are traceable to ZY common stock pursuant to the registration statement and prospectus published in connection with the company’s initial public offering in April 2021 can visit www.tenlaw.com/cases/Zymergen for more information Contact the Thornton Law Firm’s investor protection team. Investors can also email investoren@tenlaw.com or call 617-531-3917.

MORE INFORMATION: www.tenlaw.com/cases/Zymergen

In the case, it is alleged that Zymergen’s registration statement was essentially false and misleading and did not indicate that: (i) key customers had encountered technical issues during the Hyaline qualification process, including product shrinkage and incompatibility with customers’ processes; (ii) Although the qualification process was critical to Hyaline market adoption and revenue generation, Zymergen lacked insight into the qualification process; (iii) Zymergen has therefore overestimated the demand for its products; and (iv) consequently Zymergen’s delivery time was likely to have been delayed, which in turn would delay revenue generation.

Interested Zymergen investors have until October 4, 2021 to hire an attorney and apply as the lead plaintiff if they are interested. A lead plaintiff is acting on behalf of all other members of the investor group in administering the class action. Investors don’t have to be a lead plaintiff to be a class plaintiff. If investors do nothing, they can remain an absent member of the class. The class is not yet certified. Investors are not represented by a lawyer until they have been certified. Thornton law firm is not currently representing a plaintiff who has filed a complaint but is investigating the case on behalf of investors interested in being lead plaintiffs.

MORE INFORMATION: www.tenlaw.com/cases/Zymergen

Thornton Law Firm’s securities attorneys are very experienced in representing investors in claiming damages caused by violations of securities laws. His attorneys have a track record of litigating securities cases in courts across the country and recovering losses on behalf of investors. This may be considered a lawyer solicitation in some jurisdictions. Past results do not guarantee or predict a similar result with respect to future matters.

CONTACT:

Thornton Law Firm LLP

1 Lincoln Street

State Street Financial Center

Boston, MA 02111

www.tenlaw.com/cases/Zymergen

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/92816

Comments are closed.